CompletedNCT00809731
Official study titleA Naturalistic Observational Study to Evaluate Efficacy of 2nd-generation Antipsychotics and Remission Status for Patients With Schizophrenia / Schizoaffective Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including ChanghuaSchizophreniaObservational studyAges 18–65
- Countries
- Taiwan
- Sponsor
- AstraZeneca
CompletedNCT05866328
Official study titleOnline Training Program on Social Cognition for Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In San Cristóbal de La LagunaSchizophreniaInterventional studyAges 18–65
- Countries
- Spain
- Sponsor
- University of La Laguna
CompletedNCT01451736
Official study titleClinical and Cognitive Effects of Paliperidone Palmitate vs. Oral Risperidone in First-Episode Schizophrenia
This study has finished and is no longer accepting participants.
In Los AngelesSchizophreniaMedication studyAges 18–45
- Countries
- United States
- Sponsor
- University of California, Los Angeles
CompletedNCT04191200
Official study titleEtat BUCCO-dentaire de Patients Atteints de SCHIZophrénie et de Troubles Schizo-affectif Suivis au Centre Hospitalier de Charles Perrens
This study has finished and is no longer accepting participants.
In BordeauxSchizophreniaObservational studyAges 18+
- Countries
- France
- Sponsor
- Centre Hospitalier Charles Perrens, Bordeaux
CompletedNCT00330551
Official study titleEffects of Risperdal Consta Versus Oral Antipsychotic Medication on Clinical and Functional Outcome and Neurocognition in First-episode Schizophrenia
This study has finished and is no longer accepting participants.
In Los AngelesSchizophreniaMedication studyAges 18–45
- Countries
- United States
- Sponsor
- University of California, Los Angeles
CompletedNCT04176835
Official study titleNeurobiological Effects of Oxytocin on Social Decision Making in Schizophrenia: A Pharmacological MRI Study
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 18–45
- Countries
- Sponsor
- National Institute of Mental Health and Neuro Sciences, India
CompletedNCT01012167
Official study titleOxytocin or Galantamine vs. Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including BaltimoreSchizophreniaMedication studyAges 18–64
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
Active Not RecruitingNCT01545999
Official study titlePaired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia: a Combined Transcranial Magnetic Stimulation and Electroencephalography Study Across the Life Span
This study is no longer accepting new participants.
In TorontoSchizophreniaInterventional studyAges 18–60
- Countries
- Canada
- Sponsor
- Centre for Addiction and Mental Health (Hospital / academic medical center)
CompletedNCT03246932
Official study titleThe Effectiveness of a Peer-led Psycho-education Group in Schizophrenia: A Multi-site Randomised Controlled Trial
This study has finished and is no longer accepting participants.
Multiple locations, including Jilin CitySchizophreniaBehavioural studyAges 18–64
- Countries
- China
- Sponsor
- Chinese University of Hong Kong
CompletedNCT04094207
Official study titleThe Phosphodiesterase Inhibitor Pentoxifylline as an Adjunctive in Treatment of Negative Symptoms in Chronic Schizophrenia: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
This study has finished and is no longer accepting participants.
In Shibīn al KawmSchizophreniaMedication studyAges 18–50
- Countries
- Egypt
- Sponsor
- Sadat City University
CompletedNCT05109065
This study has finished and is no longer accepting participants.
In StanfordSchizophreniaObservational studyAges 18–40
- Countries
- United States
- Sponsor
- Stanford University
CompletedNCT06732817
Official study titlePersonalized Repetitive Transcranial Magnetic Stimulation for Patients with Refractory Schizophrenia: an Open-label Study
This study has finished and is no longer accepting participants.
In HefeiSchizophreniaDevice studyAges 18–60
- Countries
- China
- Sponsor
- Anhui Medical University